Comparative efficacy and safety of anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: systematic review and Bayesian network meta-analysis

BACKGROUND: As a debilitating neurodegenerative disease, neovascular age-related macular degeneration (nAMD) accounts for more than 90% of severe visual loss or legal blindness among AMD patients. Anti-vascular endothelial growth factor (VEGF) had been applied widely in nAMD treatment. To date, deba...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lu, Jiaqi, Zhao, Jianchao, Wang, Zhaohui, Feng, Liang, Yao, Xiaohui, Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475790/
https://www.ncbi.nlm.nih.gov/pubmed/32953000
http://dx.doi.org/10.1177/2040622320953349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475790/
https://www.ncbi.nlm.nih.gov/pubmed/32953000
http://dx.doi.org/10.1177/2040622320953349

Ejemplares similares